Comanche Biopharma
comanchebiopharma.com
Actively hiring
Design & Creative
Biotechnology
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$73.6M
2 rounds on record
Latest round
$37.5M
Venture round · Dec 2023 · 2 yr ago
Team
51-200
employees, estimated range
Backers
2
Atlas Venture, Broadview Ventures
The money's age
Long since its last round
33 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 14, 2023
Raised a round Venture round $37.5M · SEC Form D
Jun 28, 2021
Raised a round Venture round $36.1M · SEC Form D
2020
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2023 | $37.5M | — | SEC Form D |
| Venture round | Jun 2021 | $36.1M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Comanche Biopharma Corp. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Paul AntinoriExecutive OfficerSEC Form D
Allison AugustExecutive OfficerSEC Form D
Michael YoungExecutive OfficerSEC Form D
Thomas JohnsonExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Atlas Venture 
Broadview Ventures Similar startupsby what they do, their industry and backers
VisiPlate by Avisi Technologies is an investigational implant designed to lower intraocular pressure in patients with open-angle glaucoma.
Discover how Day One Biopharmaceuticals is disrupting the status quo of traditional drug development to bring new medicines to children and…
Developing new medicines from fungi using AI.
Discover our mission and how the BUSUP project was born. Our purpose is to link employees, companies and bus operators.
Submit Connect Investigational Use Only. Products under development by Ventaris are investigational medical devices and are not approved or…
A Boston-based biotech startup developing medicines for patients with autoinflammatory disease.
People
Paul Antinori
Executive Officer
Allison August
Executive Officer
Michael Young
Executive Officer
Thomas Johnson
Executive Officer, Director
Arthur Levin
Director
Brendan Bulik-Sullivan
Director
Muzammil Mansuri
Director
Ann Taylor
Director
Clive Meanwell
Director
Allyson Felix
Director
Ketan Patel
Director
David Grayzel
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Concord
United States
HQ
Contact Us
50-200 est. staff
Concord, MA 01742